Effect of Ingested Interferon-α on β-Cell Function in Children With New-Onset Type 1 Diabetes

OBJECTIVE: To evaluate the safety and efficacy of ingested human recombinant interferon-α (hrIFN-α) for preservation of β-cell function in young patients with recent-onset type 1 diabetes. RESEARCH DESIGN AND METHODS: Subjects aged 3–25 years in whom type 1 diabetes was diagnosed within 6 weeks of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Rother, Kristina I., Brown, Rebecca J., Morales, Miriam M., Wright, Elizabeth, Duan, Zhigang, Campbell, Carol, Harlan, David M., Orlander, Philip R., Brod, Staley A., Hardin, Dana S., Popovic, Jadranka, McEvoy, Robert C.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699745/
https://www.ncbi.nlm.nih.gov/pubmed/19564474
http://dx.doi.org/10.2337/dc08-2029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699745/
https://www.ncbi.nlm.nih.gov/pubmed/19564474
http://dx.doi.org/10.2337/dc08-2029

Ejemplares similares